FdaApplication
NDA 218490
Identifiers
- fda_app_no: NDA218490
Properties
| Property | Value |
|---|---|
| applicant_name | ACTELION PHARMACEUTICALS US INC |
| application_type | NDA |
| approval_date | 2024-03-22 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OPSYNVI | MACITENTAN; TADALAFIL | 10MG;20MG | TABLET;ORAL |
| OPSYNVI | MACITENTAN; TADALAFIL | 10MG;40MG | TABLET;ORAL |
2 products